Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ricard Cervera

Showing results (321-330 of 412) with videos related to

Pageof 42
Sort By:
Arthritis Care & Research|September 28, 2019
Associations Between Classification Criteria Items in Systemic Lupus ErythematosusZahi Touma, Ricard Cervera, Ralph Brinks, et al.
Autoimmunity Reviews|August 25, 2015
Clinical and genetic characterization of the autoinflammatory diseases diagnosed in an adult reference centerJosé Hernández-Rodríguez, Estíbaliz Ruíz-Ortiz, Adrià Tomé, et al.
Arthritis and Rheumatism|December 1, 2011
A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosusRichard Furie, Michelle Petri, Omid Zamani, et al.
Annals of the Rheumatic Diseases|February 19, 2024
Molecular characterisation of lupus low disease activity state (LLDAS) and DORIS remission by whole-blood transcriptome-based pathways in a pan-European systemic lupus erythematosus cohortIoannis Parodis, Julius Lindblom, Guillermo Barturen, et al.
Medicine|May 9, 2002
HLA class II DNA typing in a large series of European patients with systemic lupus erythematosus: correlations with clinical and autoantibody subsetsMauro Galeazzi, Gian Domenico Sebastiani, Gabriella Morozzi, et al.
Autoimmunity Reviews|August 5, 2023
From systemic lupus erythematosus to lupus nephritis: The evolving road to targeted therapiesMarc Xipell, Gema M Lledó, Allyson C Egan, et al.
Annals of the Rheumatic Diseases|June 21, 2020
Genome-wide whole blood transcriptome profiling in a large European cohort of systemic sclerosis patientsLorenzo Beretta, Guillermo Barturen, Barbara Vigone, et al.
Arthritis Research & Therapy|November 26, 2020
Discordance between patient and physician global assessment of disease activity in Behçet's syndrome: a multicenter study cohortAlberto Floris, Gerard Espinosa, Luisa Serpa Pinto, et al.
Rheumatology (Oxford, England)|June 13, 2026
Prevalence and prognostic value of activated protein C resistance and anti-protein C antibodies in patients with antiphospholipid antibodies: an APS ACTION Registry studyIbrahim Tohidi-Esfahani, Veronica Venturelli, Maria Tektonidou, et al.
ACR Open Rheumatology|March 19, 2021
Beta-2-Glycoprotein-I Deficiency Could Precipitate an Antiphospholipid Syndrome-like Prothrombotic Situation in Patients With Coronavirus Disease 2019Manuel Serrano, Gerard Espinosa, Antonio Lalueza, et al.
Pageof 42

Showing results (321-330 of 412) with videos related to

Sort By:
Pageof 42
Arthritis Care & Research|September 28, 2019
Associations Between Classification Criteria Items in Systemic Lupus ErythematosusZahi Touma, Ricard Cervera, Ralph Brinks, et al.
Autoimmunity Reviews|August 25, 2015
Clinical and genetic characterization of the autoinflammatory diseases diagnosed in an adult reference centerJosé Hernández-Rodríguez, Estíbaliz Ruíz-Ortiz, Adrià Tomé, et al.
Arthritis and Rheumatism|December 1, 2011
A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosusRichard Furie, Michelle Petri, Omid Zamani, et al.
Annals of the Rheumatic Diseases|February 19, 2024
Molecular characterisation of lupus low disease activity state (LLDAS) and DORIS remission by whole-blood transcriptome-based pathways in a pan-European systemic lupus erythematosus cohortIoannis Parodis, Julius Lindblom, Guillermo Barturen, et al.
Medicine|May 9, 2002
HLA class II DNA typing in a large series of European patients with systemic lupus erythematosus: correlations with clinical and autoantibody subsetsMauro Galeazzi, Gian Domenico Sebastiani, Gabriella Morozzi, et al.
Autoimmunity Reviews|August 5, 2023
From systemic lupus erythematosus to lupus nephritis: The evolving road to targeted therapiesMarc Xipell, Gema M Lledó, Allyson C Egan, et al.
Annals of the Rheumatic Diseases|June 21, 2020
Genome-wide whole blood transcriptome profiling in a large European cohort of systemic sclerosis patientsLorenzo Beretta, Guillermo Barturen, Barbara Vigone, et al.
Arthritis Research & Therapy|November 26, 2020
Discordance between patient and physician global assessment of disease activity in Behçet's syndrome: a multicenter study cohortAlberto Floris, Gerard Espinosa, Luisa Serpa Pinto, et al.
Rheumatology (Oxford, England)|June 13, 2026
Prevalence and prognostic value of activated protein C resistance and anti-protein C antibodies in patients with antiphospholipid antibodies: an APS ACTION Registry studyIbrahim Tohidi-Esfahani, Veronica Venturelli, Maria Tektonidou, et al.
ACR Open Rheumatology|March 19, 2021
Beta-2-Glycoprotein-I Deficiency Could Precipitate an Antiphospholipid Syndrome-like Prothrombotic Situation in Patients With Coronavirus Disease 2019Manuel Serrano, Gerard Espinosa, Antonio Lalueza, et al.
Pageof 42